During the past 12 months, Co-Diagnostics's average Revenue per Share Growth Rate was -42.90% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -55.70% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 173.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
During the past 9 years, the highest 3-Year average Revenue per Share Growth Rate of Co-Diagnostics was 1286.10% per year. The lowest was -55.70% per year. And the median was 337.30% per year.
Competitive Comparison of Co-Diagnostics's 3-Year Revenue Growth Rate
For the Medical Devices subindustry, Co-Diagnostics's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Co-Diagnostics's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Co-Diagnostics's 3-Year Revenue Growth Rate distribution charts can be found below:
* The bar in red indicates where Co-Diagnostics's 3-Year Revenue Growth Rate falls into.
This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.
Co-Diagnostics 3-Year Revenue Growth Rate Related Terms
Thank you for viewing the detailed overview of Co-Diagnostics's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
Co-Diagnostics (Co-Diagnostics) Business Description
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV. The company's diagnostics systems enable very rapid, low-cost, sophisticated molecular testing for organisms and genetic diseases by greatly automating historically complex procedures in both the development and administration of tests.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CODX has been successfully added to your